SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration

Jia-Long Qi,Jin-Rong He,Cun-Bao Liu,Shu-Mei Jin,Xu Yang,Hong-Mei Bai,Yan-Bing Ma,Jia-long Qi,Jin-rong He,Cun-bao Liu,Shu-mei Jin,Hong-mei Bai,Yan-bing Ma
DOI: https://doi.org/10.1016/j.gendis.2021.03.008
2021-04-01
Abstract:<p>The autophagy adaptor protein SQSTM1/p62 is overexpressed in breast cancer and has been identified as a metastasis-related protein. However, the mechanism by which SQSTM1/p62 contributes to breast cancer progression and tumor microenvironment remains unclear. This study revealed that silencing SQSTM1/p62 expression suppressed breast cancer progression via regulating cell proliferation and reshaping the tumor microenvironment (TME). Here, we found that SQSTM1/p62 was overexpressed in multiple human cancer tissue types and that was correlated with poor patient overall survival (OS) and disease-free survival (DFS). Moreover, we found that short-hairpin RNA (shRNA)-mediated knockdown of p62 expression significantly inhibit cell proliferation, migration, invasion, and promoted cell death <em>in vitro</em>, as well as suppressed breast cancer growth and lung metastasis <em>in vivo</em>. In addition, flow cytometry analysis of splenocytes and tumor infiltration lymphocytes (TILs) indicated that the numbers of CD8α<sup>+</sup> interferon (IFN)-γ<sup>+</sup> cells (CTLs) and CD4<sup>+</sup>IFN-γ<sup>+</sup> (Th1) cells were increased while those of CD4<sup>+</sup>IL-4<sup>+</sup> (Th2) cells, tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) were decreased. RT-PCR analyses showed that the gene expression of Th1/Th2 cytokines changed in the tumor microenvironment. Silencing SQSTM1/p62 suppress tumor cell lung metastasis. Together, our results provide strong evidence that silencing tumor cell SQSTM1/p62 inhibit tumor growth and metastasis through cell cycle arrest and TME regulation. This finding provides a novel molecular therapeutic strategy for breast cancer progression and metastasis treatment.</p>
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?